Mental Health Aspects of Mass Violence: September 2020

3.00 CME
180 MINS
$30 FEE
SAVE

Table of Contents

School Shootings Revisted for Clinicians

Eleanor Lastrapes, MD; Bailey Vasquez, BS; Heather Baker, LCSW; Julio I. Rojas, PhD, LADC; and Britta K. Ostermeyer, MD, MBA

The Role of Mental Health in the Aftermath of Terrorism

Ashley H. VanDercar, MD, JD; Grace L. Whaley, LMSW; Erin M. Hawks, PhD; and Britta K. Ostermeyer, MD, MBA

Risk and Resilience in Children in the Context of Mass Trauma

Grace L. Whaley, LMSW; Vandana Varma, MD; Erin M. Hawks, PhD; Robyn Cowperthwaite, MD; Lenore Arlee, LCSW; and Betty Pfefferbaum, MD, JD

The Influence of Media Related to Mass Shootings

Praveen R. Kambam, MD; Vasilis K. Pozios, MD; Kerry L. Bond, MSW, LCSW; and Britta K. Ostermeyer, MD, MBA

Sponsorship Statement: This CME activity is jointly sponsored by AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals.

Support Statement: There is no commercial support for this activity.

Learning Objectives:

  1. Identify clinically relevant information on people who commit school shootings.
  2. Describe the role of mental health professionals in the aftermath of terrorism.
  3. Describe risk and protective factors for children’s emotional recovery from mass trauma.
  4. Recognize media influence warning signs that may suggest the need for further assessment or forensic/threat assessment referral.

Author names and affiliations:  See authors above

Guest Editor: Britta K. Ostermeyer, MD, MBA

Reviewer names:  Andrew A. Nierenberg, MD, Editor, and Lenard A. Adler, MD, CME Coordinator, Psychiatric Annals

Disclosure statement:  In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears at the beginning of each CME-accredited article in this issue and also on this page.

Faculty members report the following financial relationships:  Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly and Company; EpiQ, Forest; Johnson and Johnson; Labopharm; Merck; Methylation Science; Novartis; PamLabs; PGx Health; Shire; Schering-Plough; Sunovion; Takeda/Lundbeck Pharmaceuticals; Targacept; Teva: Consultant. APSARD; Belvoir Publishing; Boston Center for the Arts; University of Texas Southwestern Dallas; Hillside Hospital; American Drug Utilization Review; American Society for Clinical Psychopharmacology; Bayamon Region Psychiatric Society; Baystate Medical Center; Canadian Psychiatric Association; Columbia University; Douglas Hospital/McGill University; IMEDEX; International Society for Bipolar Disorders; Israel Society for Biological Psychiatry; John Hopkins University; MJ Consulting; Massachusetts Association of College Counselors; Medscape; MBL Publishing; Physicians Postgraduate Press; Ryan Licht Sang Foundation; Slack Publishing; SUNY Buffalo; University of Florida; University of Miami; University of Wisconsin; University of Pisa; SciMed: Honoraria / travel expenses. Appliance Computing, Inc.; Brain Cells, Inc.: Stock options. AHRQ; Cephalon; Forest; Mylan; NIMH; PamLabs; Pfizer Pharmaceuticals; Takeda; Elan; Shire: Grant / research support.
Lenard A. Adler has disclosed the following relevant financial relationships: research grants paid to New York University (NYU) on Dr. Adler’s behalf from Sunovion Pharmaceuticals, Shire Pharmaceuticals, Lundbeck, Enzymotec, Purdue Pharma; personal fees for consulting or advisory boards from Sunovion Pharmaceuticals, Enzymotec, Shire Pharmaceuticals, the National Football League, Major League Baseball, Shire Pharmaceuticals, Otsuka Pharmaceuticals, Alcobra Pharmaceuticals; and royalty fees from NYU School of Medicine for license of Adult ADHD rating scales and training materials.

Authors report the following financial relationships: Eleanor Lastrapes has no relevant financial relationships to disclose. Bailey Vasquez has no relevant financial relationships to disclose. Heather Baker has no relevant financial relationships to disclose. Julio I. Rojas has no relevant financial relationships to disclose. Britta K. Ostermeyer has no relevant financial relationships to disclose. Ashley H. VanDercar has no relevant financial relationships to disclose. Grace L. Whaley has no relevant financial relationships to disclose. Erin M. Hawks has no relevant financial relationships to disclose. Vandana Varma has no relevant financial relationships to disclose. Robyn Cowperthwaite has no relevant financial relationships to disclose. Lenore Arlee has no relevant financial relationships to disclose. Betty Pfefferbaum has no relevant financial relationships to disclose. Praveen R. Kambam has no relevant financial relationships to disclose. Vasilis K. Pozios has no relevant financial relationships to disclose. Kerry L. Bond has no relevant financial relationships to disclose..

Accreditation statement(s):  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and SLACK Incorporated. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

Credit designation: AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 3.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Release date:  September 1, 2020.  Expiration Date:  October 1, 2023.

How to participate:  To participate in this CME activity, you must read the learning objectives, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, AKH Inc., Advancing Knowledge in Healthcare will issue an AMA PRA Category 1 Credit(s)™ certificate.

Target audience:  This CME activity is primarily targeted to patient-caring psychiatrists, physicians specializing in psychiatry, and others allied to the field. There are no specific background requirements for participants taking this activity.

Unlabeled and investigational usage statement:  The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The authors have been made aware of their obligation to disclose such usage.